These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33143687)

  • 41. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
    Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
    Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L.
    Izumi S; Hagiwara Y; Matsuyama Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
    Health Qual Life Outcomes; 2023 Jan; 21(1):3. PubMed ID: 36650539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
    Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
    JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches.
    Khan I; Morris S
    Health Qual Life Outcomes; 2014 Nov; 12():163. PubMed ID: 25388439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
    Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
    Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.
    Yang F; Wong CKH; Luo N; Piercy J; Moon R; Jackson J
    Eur J Health Econ; 2019 Nov; 20(8):1195-1206. PubMed ID: 31338698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.
    Yu L; Yang H; Lu L; Fang Y; Zhang X; Li S; Li C
    Health Qual Life Outcomes; 2024 Aug; 22(1):61. PubMed ID: 39113080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.
    Crott R; Briggs A
    Eur J Health Econ; 2010 Aug; 11(4):427-34. PubMed ID: 20473703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure.
    Kularatna S; Senanayake S; Chen G; Parsonage W
    Health Qual Life Outcomes; 2020 Apr; 18(1):115. PubMed ID: 32349782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients.
    Lloyd AJ; Kerr C; Penton J; Knerer G
    Value Health; 2015 Dec; 18(8):1152-7. PubMed ID: 26686802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.
    Lamu AN; Chen G; Gamst-Klaussen T; Olsen JA
    Qual Life Res; 2018 Jul; 27(7):1801-1814. PubMed ID: 29569014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients.
    Wu EQ; Mulani P; Farrell MH; Sleep D
    Value Health; 2007; 10(5):408-14. PubMed ID: 17888106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease.
    Li C; Dou L; Fu Q; Li S
    Health Qual Life Outcomes; 2023 Jul; 21(1):64. PubMed ID: 37400827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.
    Tan YJ; Ong SC
    Value Health; 2024 Dec; 27(12):1762-1770. PubMed ID: 39127252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients.
    Pan CW; He JY; Zhu YB; Zhao CH; Luo N; Wang P
    Eur J Health Econ; 2023 Aug; 24(6):885-893. PubMed ID: 36083356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
    Yang Q; Yu XX; Zhang W; Li H
    Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique.
    Gao L; Luo W; Tonmukayakul U; Moodie M; Chen G
    Eur J Health Econ; 2021 Mar; 22(2):341-350. PubMed ID: 33438134
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.